Novo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook

0


Top view of calculator,glasses,pen,plant and notebook written with First Quarter on wooden background.Business and finance concept.

Mohamad Faizal Bin Ramli

  • Novo Nordisk press release (NVO): Q1 GAAP EPADR of DKK 5.68.
  • Revenue of DKK 65.35B (+22.4% Y/Y).
  • For the 2024 outlook, sales growth is now expected to be 19-27% at CER, and operating profit growth is now expected to be 22-30% at CER. Growth



Source link

Leave A Reply

Your email address will not be published.